Illumina bags $40M for incubator startups; ERT strikes eCOA merger;

> Illumina ($ILMN) secured $40 million from Viking Global Investors to support startups that emerge from its incubator. News

> ERT struck a deal to acquire its rival electronic clinical outcome assessment vendor PHT. Release

> Lupin Pharmaceuticals picked Acceliant as its trial data management service provider. Item

> TransCelerate selected DrugDev as the developer and host of its registry of clinical trial investigators. More

> Medidata ($MDSO) inked a deal to provide cloud and mobile tech to a 10-year pediatric rheumatology data gathering program. News

> LifeMap Sciences teamed up with Toldot Genetics on NGS data analysis. Post

> 10X Genomics provided more details about its synthetic long read machine, GemCode. The first devices are due to ship in the second quarter. Article | More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.